Argenx
ARGX
516,73 €
Share price
-2.94%
Change (1 day)
48.06%
Change (1 year)
Categories
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.
Argenx (ARGX) - Net assets
Net assets on the balance sheet as of December 2024 : €4.83 Billion
According to Argenx
's latest financial reports the company has €4.83 Billion in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Argenx - Net assets on balance sheet (from 2013 to 2020)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2020-12-31 | $€1.67 B | 41.82% |
| 2019-12-31 | $€1.18 B | 91.66% |
| 2018-12-31 | $€0.61 B | 48.83% |
| 2017-12-31 | $€0.41 B | 520.87% |
| 2016-12-31 | $€66.65 M | 63.54% |
| 2015-12-31 | $€40.75 M | -33.08% |
| 2014-12-31 | $€60.9 M | 103.19% |
| 2013-12-31 | $€29.97 M | 79.99% |
| 2012-12-31 | $€16.65 M | -40.31% |
| 2011-12-31 | $€27.89 M | 172.65% |
| 2010-12-31 | $€10.23 M |